Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Aggression × Etoposide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 24 Leukemia, Myeloid, Acute 24 Precursor Cell Lymphoblastic Leukemia-Lymphoma 23 Leukemia 22 Lymphoma 20 Lymphoma, Non-Hodgkin 18 Burkitt Lymphoma 18 Small Cell Lung Carcinoma 17 Lung Neoplasms 12 Leukemia, Lymphocytic, Chronic, B-Cell 12 Lymphoma, Mantle-Cell 11 Lymphoma, Follicular 11 Congenital Abnormalities 11 Recurrence 10 Myelodysplastic Syndromes 10 Brain Neoplasms 10 Neuroblastoma 9 Hodgkin Disease 9 Lymphoma, Large-Cell, Immunoblastic 8 Lymphoma, B-Cell, Marginal Zone 8 Leukemia, Myeloid, Accelerated Phase 8 Leukemia, Monocytic, Acute 8 Leukemia, Megakaryoblastic, Acute 8 Leukemia, Erythroblastic, Acute 8 Blast Crisis 8 Myeloproliferative Disorders 7 Multiple Myeloma 7 Leukemia, Myelomonocytic, Acute 7 Sarcoma 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6

Interventions

selinexor 1 Rituximab 1 Ifosfamide 1 Etoposide 1 Dexamethasone 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡